A Review of Newly Diagnosed Glioblastoma
Bryan Oronsky, Tony R. Reid, Arnold L. Oronsky, Navjot Sandhu, Susan J. Knox
Abstract
Glioblastoma is an aggressive and inevitably recurrent primary intra-axial brain tumor with a dismal prognosis. The current mainstay of treatment involves maximally safe surgical resection followed by radiotherapy over a 6-week period with concomitant temozolomide chemotherapy followed by temozolomide maintenance. This review provides a summary of the epidemiological, clinical, histologic and genetic characteristics of newly diagnosed disease as well as the current standard of care and potential future therapeutic prospects.
Topics & Concepts
TemozolomideMedicineConcomitantGlioblastomaRadiation therapyOncologyChemotherapyDiseaseEpidemiologyInternal medicineSurgeryCancer researchGlioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismBrain Tumor Detection and Classification